International Journal of Hematology

Article	Citations
Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/β-thalassemia and those achieving successful hematopoietic stem-cell transplantation	72
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma	68
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment	40
EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells	39
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature	34
Carcinocythemia diagnosed on peripheral blood clot sections	30
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study	24
Treatment-related sequelae in Hodgkin’s lymphoma after mediastinal irradiation	23
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan	23
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy	22
Anti-Fya-mediated delayed hemolytic transfusion reaction following emergency-release red blood cell transfusion: possible involvement of HLA-DRB1*04:03 in the Japanese population	21
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice	21
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib	20
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells	20
Post-transfusion purpura and adult primary thrombocytopenia	19
Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors	18
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era	18
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma	18
Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan	17
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia	17
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets	17
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST	17
Isolated thrombosis after COVID-19 vaccination: case series	16
Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma	16
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia	15

Primary pancreatic diffuse large B-cell lymphoma, appearing as an asymptomatic bulky mass with the duct-penetrating sign	14
JSH practical guidelines for hematological malignancies, 2023: II. lymphoma—overview	14
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy	14
Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma	13
SPAG6 regulates cell proliferation and apoptosis via TGF-β/Smad signal pathway in adult B-cell acute lymphoblastic leukemia	13
Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study	13
HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA	13
Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors	13
Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)	13
Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia	12
A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia	12
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus	12
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)	12
Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia–telangiectasia caused by novel compound heterozygous variants in ATM	11
Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic	11
Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a	11
Armor sign on PET–CT in a young male with non-Hodgkin’s lymphoma	11
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A	11
Incidence and risk factors of late-onset hemorrhagic cystitis after single umbilical cord blood transplantation with myeloablative conditioning regimen	11
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome	10
Guest Editorial: what can be done to improve cancer immunotherapies?	10
Ten years’ experience in prenatal diagnosis of α-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities	10
Comparative inhibitory effects of bepotastine and diphenhydramine on rituximab-induced infusion reactions	10
Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study	10
Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays	10
Current and emerging therapeutic strategies in adult T-cell leukemia–lymphoma	10
Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma	10
Evolution and optimization of therapies for acute lymphoblastic leukemia in infants	10
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome	9
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation	9
Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic	9
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia	9
Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds	9
Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia	9
Combined tumor necrosis factor-α (−308 G/A) and tumor necrosis factor-β (+ 252 A/G) nucleotide polymorphisms and chronicity in Egyptian children with immune thrombocytopenia	9
Assay variables and early clinical evaluation of low-angle light scattering for platelet function analysis	9
Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation	9
Effect of delivery mode on postnatal platelet count dynamics in neonates born to mothers with immune thrombocytopenia	9
Correction to: A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)	9
Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies	9
Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution	9
Optimization of lymphapheresis for manufacturing autologous CAR-T cells	9
DLI-induced remission in recurrent EBV-associated T/NK-cell lymphoproliferative disease following HSCT: a case report	8
Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia	8
Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants	8
Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach	8
Correction to: Patient’s age and D‑dimer levels predict the prognosis in patients with TAFRO syndrome	8
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study	8
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023	8
An adult case of refractory autoimmune neutropenia after liver transplantation	8

Auer rods in mature granulocytes in peripheral blood	8
Detection of Talaromyces marneffei in a HIV-infected patient from peripheral blood observation through Sysmex XN WNF/WNR channels	8
Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice	8
Multiple myeloma with high-risk cytogenetics and its treatment approach	8
Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation	8
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit	8
Clinical features of immature leukemias in children	8
Therapy-related acute myeloid leukemia with inv(16)(p13.1q22)	8
Nodal mature plasmacytoid dendritic cell proliferation mimicking lymphoma in a patient with CALR-mutated myelofibrosis	8
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia	7
Retrospective analysis of treatment discontinuation in minimal residual disease negative multiple myeloma	7
Sarcopenia and clinical outcomes in lymphoma and multiple myeloma patients receiving hematopoietic cell transplantation: a systematic review and meta-analysis	7
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era	7
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial	7
Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia	7
Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system	7
Resilient T-cell responses in patients with advanced cancers	7
Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients	7
A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation	7
Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia	7
COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm	7
Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia	7
Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol	7
Risk prediction for delayed clearance of high-dose methotrexate in pediatric hematological malignancies by machine learning	7
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)	7
Pseudo-Chediak–Higashi inclusions and Auer rods in a case of therapy-related acute monocytic leukemia	6
Prognostic value of lymphoid marker CD7 expression in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in first morphological complete remission	6
Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantation	6
A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial	6
Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia	6
Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation	6
Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation	6
Leukemic-phase mucosa-associated lymphoid tissue lymphoma	6
Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI)	6
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis	6
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases	6
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study	6
Correction to: Somatic SETBP1 mutations in myeloid neoplasms	6
Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review	6
Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes	6
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid	6
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag	6
A phase 2 trial of VRD induction for transplant-eligible Japanese patients with newly diagnosed multiple myeloma	6
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series	6
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia	6
Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency	5
Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB	5
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review	5
Guest editorial: recent progress in pediatric leukemia	5
Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children	5
Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells	5
Correction: JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL)	5
Fulminant type I cryoglobulinemic glomerulonephritis with unique ultrastructural plugs: a case report	5
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors	5
Dysregulated hemostasis in acute promyelocytic leukemia	5
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency	5
Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation	5
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center	5
An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma	5
Recent advances in AML with mutated NPM1	5
HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia	5
FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloanti	5
FLT3 targeting in the modern era: from clonal selection to combination therapies	5
Favorable prognosis of vaccine-associated immune thrombocytopenia in children is correlated with young age at vaccination: Retrospective survey of a nationwide disease registry	5
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio	5
Mature T-cell and NK-cell lymphomas: updates on molecular genetic features	5
The mutual crosstalk between iron and erythropoiesis	5
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis	5
Neuropeptide TIP39 induces autophagy in PTH2 receptor-positive myeloid neoplasms	5
JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL)	5
Hematopoietic cell transplantation in pediatric EB virus-associated hemophagocytic lymphohistiocytosis	5
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM	5
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 4. Mantle cell lymphoma (MCL)	5
Heme as a differentiation-regulatory transcriptional cofactor	5
Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study	5
Clinical diagnostic accuracy of respiratory failure in critically ill hematopoietic stem cell transplant patients	5
Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marke	5
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes	5
Correction to: Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?	5
Recent advances in understanding the biology of follicular lymphoma	5

Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia	5
Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura	5
Bilateral development of biclonal ocular adnexal marginal zone lymphoma at a 2-year interval	5
A case of posttransplant isolated extramedullary relapse of acute lymphoblastic leukemia achieving durable treatment-free remission with blinatumomab and donor lymphocyte infusion	5
Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation	4
Stem cell regulation and dynamics in myeloid malignancies	4
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma5. Diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS)	4
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease	4
Bringing mass spectrometry into the care of patients with multiple myeloma	4
Prevention of acute graft-versus-host disease in adult T-cell leukemia–lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation	4
Bosutinib-induced lung injury: a report of two cases and literature review	4
NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein–Barr virus infection	4
Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease	4
Correction: Real‑world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis o	4
Retrospective comparison of reinfusion procedures and subsequent leukopenia in autologous stem cell transplantation	4
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study	4
Blasts engulfing erythrocytes: an unusual morphological finding in adult early T-precursor acute lymphoblastic leukemia	4
Reply to the Dr. Murphy’s comment	4
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line	4
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination	4
Anakinra for the treatment of adult secondary HLH: a retrospective experience	4
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia	4
Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development	4
Novel immunotherapies in multiple myeloma	4
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria	4
Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic	4
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine	4
In vitro evaluation of global coagulation potential of emicizumab and warfarin using rotational thromboelastometry	4
Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency	4
Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1	4
Vedolizumab for children with intestinal graft-versus-host disease: a case report and literature review	4
Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis	4
Factor XII deficiency: a clinical and molecular genetic study	4
Septic shock caused by Capnocytophaga canimorsus in a patient with heterozygous Pelger-Huët anomaly	4
Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution	4
Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma	4
Multifocal osteonecrosis after stem cell transplantation	4
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples	4
Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes	4
VEXAS syndrome	4
Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report	4
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan	4
Epigenetics in lymphocyte and lymphoma: EZH2 as an easy-to-access therapeutic target?	4
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation	4
A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation	3
Prediction of major bleeding events in 1381 patients with essential thrombocythemia	3
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin–aldosterone–angiotensin system inhibitors in patients with chronic myelogenous leukemia	3
Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy	3
Iliopsoas haemorrhage complicated by femoral neuropathy in patients with haemophilia: a case series report	3
Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation	3
Impact of center volume on acute graft versus host disease in allogeneic stem cell transplant recipients	3
Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm	3
T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia	3
Improved survival among elderly patients with aggressive adult T-cell leukemia/lymphoma: Impact of mogamulizumab-containing chemotherapy	3
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation	3
Chronic graft-versus-host disease myelitis successfully treated with rituximab	3
Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine–bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma	3
Higher incidence of thrombocytopenia during obinutuzumab plus bendamustine therapy for untreated follicular lymphoma: a retrospective analysis by the Okayama Hematology Study Group	3
Effect of conditioning intensity on late complications in AYA who underwent allogeneic HCT during childhood	3
Peripartum management of hereditary thrombophilia: results of primary surveillance in Japan	3
Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by 18F-FLT PET imaging	3
Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy	3
Paranasal sinus aspergillosis in a patient treated with tirabrutinib	3
Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children’s Cancer Group	3
Histiocytic sarcoma following CAR T-cell therapy: a case report	3
Ultrasonographic monitoring of sinusoidal obstruction syndrome in patients treated with inotuzumab ozogamicin	3
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia	3
Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation	3
Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients	3
Histological confirmation and radiotherapy facilitate continuation of epcoritamab in a patient with tumor flare reaction	3
Iron deficiency and phlebotomy in patients with polycythemia vera	3
Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after fir	3
Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 p	3
Knockdown of the Shwachman-Diamond syndrome gene, SBDS, induces galectin-1 expression and impairs cell growth	3
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine	3
Vedolizumab for prevention of lower-GI acute GVHD in the Japanese subgroup analysis of the phase 3 GRAPHITE study	3
Anti-programmed cell death-1 monoclonal antibody therapy before or after allogeneic hematopoietic cell transplantation for classic Hodgkin lymphoma: a literature review	3
Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan	3
Bispecific antibodies for multiple myeloma: past, present and future	3
Inclusion of thymic Langerhans cell histiocytosis in the “5 Ts” of the differential diagnosis of anterior mediastinal mass	3
Prophylactic or pre-emptive therapies to prevent relapse after allogeneic hematopoietic stem cell transplantation	3
The characteristics and long-term outcomes of acute promyelocytic leukemia patients with early intracranial hemorrhage	3
Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva	3
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia	3
Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes	3
Very early death within 30 days after diagnosis in patients with acute myeloid leukemia	3
Ultrasonographic scoring system for SOS/VOD in pediatric hematopoietic stem cell transplant recipients	3
JSH Practical Guidelines for Hematological Malignancies, 2023: II. Lymphoma—2. Marginal zone lymphoma: MZL (extranodal marginal zone lymphoma: EMZL [extranodal marginal zone lymphoma of mucosa associa	3
Highly sensitive detection of Epstein-Barr virus-infected cells by EBER flow FISH	3
Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study	3
Quality of life of children and adolescents with hemophilia receiving low-dose prophylactic treatment	3
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives	3
Strong association between insufficient plasma exchange and fatal outcomes in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura	3
Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19)	3
Recent progress in the management of pediatric chronic myeloid leukemia	3